

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.80823120 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.77664874 |
| 3 | DNA deamination (GO:0045006) | 5.72599863 |
| 4 | chaperone-mediated protein transport (GO:0072321) | 5.20403375 |
| 5 | ATP synthesis coupled proton transport (GO:0015986) | 5.03082990 |
| 6 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.03082990 |
| 7 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.99886012 |
| 8 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.49822635 |
| 9 | protein complex biogenesis (GO:0070271) | 4.43768031 |
| 10 | viral transcription (GO:0019083) | 4.38893577 |
| 11 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.37442275 |
| 12 | maturation of SSU-rRNA (GO:0030490) | 4.32778853 |
| 13 | respiratory electron transport chain (GO:0022904) | 4.28850560 |
| 14 | translational termination (GO:0006415) | 4.27386652 |
| 15 | maturation of 5.8S rRNA (GO:0000460) | 4.24055106 |
| 16 | respiratory chain complex IV assembly (GO:0008535) | 4.23378742 |
| 17 | electron transport chain (GO:0022900) | 4.20924482 |
| 18 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.16234788 |
| 19 | NADH dehydrogenase complex assembly (GO:0010257) | 4.16234788 |
| 20 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.16234788 |
| 21 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.15810966 |
| 22 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.04228210 |
| 23 | cotranslational protein targeting to membrane (GO:0006613) | 4.03643019 |
| 24 | proteasome assembly (GO:0043248) | 4.02105943 |
| 25 | protein targeting to ER (GO:0045047) | 4.01633087 |
| 26 | ribosomal small subunit biogenesis (GO:0042274) | 4.00841049 |
| 27 | translational elongation (GO:0006414) | 4.00195644 |
| 28 | cytochrome complex assembly (GO:0017004) | 3.99785253 |
| 29 | formation of translation preinitiation complex (GO:0001731) | 3.92242108 |
| 30 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.89511178 |
| 31 | protein targeting to mitochondrion (GO:0006626) | 3.85363565 |
| 32 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.83816051 |
| 33 | protein localization to endoplasmic reticulum (GO:0070972) | 3.82644623 |
| 34 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.76573047 |
| 35 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.73693451 |
| 36 | establishment of integrated proviral latency (GO:0075713) | 3.71622579 |
| 37 | GTP biosynthetic process (GO:0006183) | 3.69865350 |
| 38 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.65860176 |
| 39 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.64590701 |
| 40 | establishment of protein localization to mitochondrion (GO:0072655) | 3.60472201 |
| 41 | translational initiation (GO:0006413) | 3.60246330 |
| 42 | DNA strand elongation (GO:0022616) | 3.60123233 |
| 43 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.59219272 |
| 44 | protein localization to mitochondrion (GO:0070585) | 3.57052663 |
| 45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.54557467 |
| 46 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.51567645 |
| 47 | negative regulation of ligase activity (GO:0051352) | 3.51567645 |
| 48 | viral life cycle (GO:0019058) | 3.47099230 |
| 49 | ribosomal large subunit biogenesis (GO:0042273) | 3.44866374 |
| 50 | translation (GO:0006412) | 3.42867320 |
| 51 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.42235614 |
| 52 | telomere maintenance via recombination (GO:0000722) | 3.41035630 |
| 53 | inner mitochondrial membrane organization (GO:0007007) | 3.40983619 |
| 54 | protein deneddylation (GO:0000338) | 3.39228713 |
| 55 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.39166121 |
| 56 | peptidyl-histidine modification (GO:0018202) | 3.37696510 |
| 57 | UTP biosynthetic process (GO:0006228) | 3.35913770 |
| 58 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.35837499 |
| 59 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.35837499 |
| 60 | establishment of viral latency (GO:0019043) | 3.34871723 |
| 61 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.33739890 |
| 62 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.33739890 |
| 63 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.33739890 |
| 64 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.33395171 |
| 65 | protein neddylation (GO:0045116) | 3.32515157 |
| 66 | cellular protein complex disassembly (GO:0043624) | 3.32432251 |
| 67 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.32136125 |
| 68 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.27291808 |
| 69 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.26071809 |
| 70 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.23747528 |
| 71 | rRNA methylation (GO:0031167) | 3.21881000 |
| 72 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.21531835 |
| 73 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.21531835 |
| 74 | DNA double-strand break processing (GO:0000729) | 3.20729447 |
| 75 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.20676566 |
| 76 | pseudouridine synthesis (GO:0001522) | 3.18828911 |
| 77 | DNA replication initiation (GO:0006270) | 3.18566966 |
| 78 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.17131069 |
| 79 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.16574127 |
| 80 | cullin deneddylation (GO:0010388) | 3.14261598 |
| 81 | DNA damage response, detection of DNA damage (GO:0042769) | 3.13518445 |
| 82 | rRNA modification (GO:0000154) | 3.13158504 |
| 83 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.12939923 |
| 84 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.12173539 |
| 85 | positive regulation of ligase activity (GO:0051351) | 3.11162734 |
| 86 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.10334504 |
| 87 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.10247046 |
| 88 | termination of RNA polymerase III transcription (GO:0006386) | 3.10247046 |
| 89 | base-excision repair, AP site formation (GO:0006285) | 3.09087891 |
| 90 | viral mRNA export from host cell nucleus (GO:0046784) | 3.08778260 |
| 91 | CTP metabolic process (GO:0046036) | 3.08473698 |
| 92 | CTP biosynthetic process (GO:0006241) | 3.08473698 |
| 93 | protein-cofactor linkage (GO:0018065) | 3.08313608 |
| 94 | intracellular protein transmembrane import (GO:0044743) | 3.07466080 |
| 95 | mitotic metaphase plate congression (GO:0007080) | 3.07289567 |
| 96 | CENP-A containing nucleosome assembly (GO:0034080) | 3.01941098 |
| 97 | ribosome biogenesis (GO:0042254) | 2.98884938 |
| 98 | telomere maintenance via telomere lengthening (GO:0010833) | 2.98602423 |
| 99 | mitotic recombination (GO:0006312) | 2.96520399 |
| 100 | rRNA processing (GO:0006364) | 2.93073885 |
| 101 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.92448580 |
| 102 | DNA replication checkpoint (GO:0000076) | 2.91939094 |
| 103 | 7-methylguanosine mRNA capping (GO:0006370) | 2.90354517 |
| 104 | protein complex disassembly (GO:0043241) | 2.89860796 |
| 105 | nucleobase biosynthetic process (GO:0046112) | 2.88424441 |
| 106 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.88416067 |
| 107 | chromatin remodeling at centromere (GO:0031055) | 2.88283632 |
| 108 | purine nucleobase biosynthetic process (GO:0009113) | 2.86694131 |
| 109 | * spliceosomal snRNP assembly (GO:0000387) | 2.86346478 |
| 110 | RNA capping (GO:0036260) | 2.83572405 |
| 111 | 7-methylguanosine RNA capping (GO:0009452) | 2.83572405 |
| 112 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.80965791 |
| 113 | purine-containing compound salvage (GO:0043101) | 2.80864354 |
| 114 | rRNA metabolic process (GO:0016072) | 2.79988069 |
| 115 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.79841100 |
| 116 | cellular component biogenesis (GO:0044085) | 2.79822199 |
| 117 | oxidative phosphorylation (GO:0006119) | 2.79335474 |
| 118 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.79110283 |
| 119 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.78800536 |
| 120 | cell cycle G1/S phase transition (GO:0044843) | 2.78800536 |
| 121 | macromolecular complex disassembly (GO:0032984) | 2.78614412 |
| 122 | signal peptide processing (GO:0006465) | 2.77896149 |
| 123 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.76522157 |
| 124 | positive regulation of cell cycle arrest (GO:0071158) | 2.76389522 |
| 125 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.75442896 |
| 126 | kinetochore assembly (GO:0051382) | 2.75236820 |
| 127 | regulation of ligase activity (GO:0051340) | 2.74761159 |
| 128 | metallo-sulfur cluster assembly (GO:0031163) | 2.74033395 |
| 129 | iron-sulfur cluster assembly (GO:0016226) | 2.74033395 |
| 130 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.73890150 |
| 131 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.69113193 |
| 132 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.68369213 |
| 133 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.65926413 |
| 134 | ribosome assembly (GO:0042255) | 2.65544011 |
| 135 | tRNA methylation (GO:0030488) | 2.65528773 |
| 136 | protein targeting to membrane (GO:0006612) | 2.64559736 |
| 137 | response to interferon-beta (GO:0035456) | 2.63321349 |
| 138 | regulation of mitochondrial translation (GO:0070129) | 2.62170493 |
| 139 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.60683236 |
| 140 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.58895303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.72171116 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.04863476 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.83713075 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.43613688 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.40742282 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.32966636 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.10181363 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.99361210 |
| 9 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.95661110 |
| 10 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.82994971 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.76463406 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.58760512 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.49949575 |
| 14 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.49356221 |
| 15 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.36101993 |
| 16 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.35396432 |
| 17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.32994749 |
| 18 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.32630829 |
| 19 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.32366414 |
| 20 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.27884102 |
| 21 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.19875926 |
| 22 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.18679814 |
| 23 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.15132882 |
| 24 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.13996809 |
| 25 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.12190587 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06695689 |
| 27 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.06441466 |
| 28 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.05573486 |
| 29 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.05513835 |
| 30 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.02857181 |
| 31 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.98211015 |
| 32 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.96273077 |
| 33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95389490 |
| 34 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.77157796 |
| 35 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.76195024 |
| 36 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.74396713 |
| 37 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.73460264 |
| 38 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.72125419 |
| 39 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.70806103 |
| 40 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.70084796 |
| 41 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.68013335 |
| 42 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65960091 |
| 43 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.63324606 |
| 44 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.62422693 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.61353168 |
| 46 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.61323475 |
| 47 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.60942279 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.60128393 |
| 49 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.58794063 |
| 50 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.58229634 |
| 51 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.57902675 |
| 52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.50432626 |
| 53 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.46029666 |
| 54 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.45739790 |
| 55 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.45346045 |
| 56 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.42714563 |
| 57 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.41783529 |
| 58 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.40950554 |
| 59 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.38897635 |
| 60 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.37299074 |
| 61 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.35236616 |
| 62 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.34559788 |
| 63 | MYC_22102868_ChIP-Seq_BL_Human | 1.33233453 |
| 64 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32651739 |
| 65 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.28729141 |
| 66 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.27157223 |
| 67 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25422904 |
| 68 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.24620589 |
| 69 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.24533335 |
| 70 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.22637226 |
| 71 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.22527210 |
| 72 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.21752778 |
| 73 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.20044617 |
| 74 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.18756087 |
| 75 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.17488308 |
| 76 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.15515709 |
| 77 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.14955233 |
| 78 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13598610 |
| 79 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07853245 |
| 80 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.07758608 |
| 81 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.07409735 |
| 82 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.07148180 |
| 83 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.06878377 |
| 84 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.04190257 |
| 85 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03276335 |
| 86 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.03185450 |
| 87 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.00996328 |
| 88 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.98861418 |
| 89 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98633559 |
| 90 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98374440 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97565775 |
| 92 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.95149079 |
| 93 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.94786873 |
| 94 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.94331618 |
| 95 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93950416 |
| 96 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.93818270 |
| 97 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.93129985 |
| 98 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.90628252 |
| 99 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.89957198 |
| 100 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89099658 |
| 101 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.89017876 |
| 102 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.88776599 |
| 103 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.87372139 |
| 104 | EWS_26573619_Chip-Seq_HEK293_Human | 0.84793200 |
| 105 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.84538355 |
| 106 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.82616427 |
| 107 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.82308068 |
| 108 | * SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.82300434 |
| 109 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.79552694 |
| 110 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78248333 |
| 111 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.77031441 |
| 112 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.76989522 |
| 113 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.75671819 |
| 114 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.73420963 |
| 115 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.72876916 |
| 116 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.72334009 |
| 117 | VDR_22108803_ChIP-Seq_LS180_Human | 0.72112156 |
| 118 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.71254418 |
| 119 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.70036734 |
| 120 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.66884549 |
| 121 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.66277985 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.82275267 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 3.23682596 |
| 3 | MP0003077_abnormal_cell_cycle | 2.81596669 |
| 4 | MP0002254_reproductive_system_inflammat | 2.69126772 |
| 5 | MP0010094_abnormal_chromosome_stability | 2.61453310 |
| 6 | MP0008007_abnormal_cellular_replicative | 2.59973547 |
| 7 | MP0003111_abnormal_nucleus_morphology | 2.57060674 |
| 8 | MP0002102_abnormal_ear_morphology | 2.49383783 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.35355067 |
| 10 | MP0008058_abnormal_DNA_repair | 2.34672204 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.33442709 |
| 12 | MP0003186_abnormal_redox_activity | 2.32079217 |
| 13 | MP0009333_abnormal_splenocyte_physiolog | 2.19007722 |
| 14 | MP0006292_abnormal_olfactory_placode | 2.03551525 |
| 15 | MP0001529_abnormal_vocalization | 2.02708499 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 2.02097441 |
| 17 | MP0009785_altered_susceptibility_to | 1.99796145 |
| 18 | MP0002938_white_spotting | 1.98969006 |
| 19 | MP0002277_abnormal_respiratory_mucosa | 1.96927098 |
| 20 | MP0000490_abnormal_crypts_of | 1.89933407 |
| 21 | MP0001853_heart_inflammation | 1.89826376 |
| 22 | MP0006054_spinal_hemorrhage | 1.86892013 |
| 23 | MP0005397_hematopoietic_system_phenotyp | 1.84240440 |
| 24 | MP0001545_abnormal_hematopoietic_system | 1.84240440 |
| 25 | MP0000685_abnormal_immune_system | 1.83319057 |
| 26 | MP0008995_early_reproductive_senescence | 1.81389102 |
| 27 | MP0008057_abnormal_DNA_replication | 1.78222236 |
| 28 | MP0008932_abnormal_embryonic_tissue | 1.75943115 |
| 29 | MP0002132_abnormal_respiratory_system | 1.72699638 |
| 30 | MP0000858_altered_metastatic_potential | 1.65073742 |
| 31 | MP0003763_abnormal_thymus_physiology | 1.64315375 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 1.62690898 |
| 33 | MP0003436_decreased_susceptibility_to | 1.62365766 |
| 34 | MP0005671_abnormal_response_to | 1.61768214 |
| 35 | MP0002163_abnormal_gland_morphology | 1.61225841 |
| 36 | MP0002837_dystrophic_cardiac_calcinosis | 1.58228672 |
| 37 | MP0002398_abnormal_bone_marrow | 1.57165537 |
| 38 | MP0008877_abnormal_DNA_methylation | 1.55655806 |
| 39 | MP0003786_premature_aging | 1.55261952 |
| 40 | MP0001986_abnormal_taste_sensitivity | 1.54712451 |
| 41 | MP0009379_abnormal_foot_pigmentation | 1.52111768 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 1.50867033 |
| 43 | MP0005025_abnormal_response_to | 1.49248416 |
| 44 | MP0004808_abnormal_hematopoietic_stem | 1.47289260 |
| 45 | MP0006072_abnormal_retinal_apoptosis | 1.47221214 |
| 46 | MP0008789_abnormal_olfactory_epithelium | 1.46922592 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.45246660 |
| 48 | MP0002736_abnormal_nociception_after | 1.41641243 |
| 49 | MP0008875_abnormal_xenobiotic_pharmacok | 1.40873455 |
| 50 | MP0003724_increased_susceptibility_to | 1.40687946 |
| 51 | MP0003656_abnormal_erythrocyte_physiolo | 1.39903958 |
| 52 | MP0002722_abnormal_immune_system | 1.39493725 |
| 53 | MP0002405_respiratory_system_inflammati | 1.36910203 |
| 54 | MP0002452_abnormal_antigen_presenting | 1.35984334 |
| 55 | MP0002019_abnormal_tumor_incidence | 1.34936858 |
| 56 | MP0003195_calcinosis | 1.34610996 |
| 57 | MP0005000_abnormal_immune_tolerance | 1.33695677 |
| 58 | MP0001800_abnormal_humoral_immune | 1.33602281 |
| 59 | MP0002429_abnormal_blood_cell | 1.33105907 |
| 60 | MP0002420_abnormal_adaptive_immunity | 1.32146818 |
| 61 | MP0001819_abnormal_immune_cell | 1.31621582 |
| 62 | MP0000716_abnormal_immune_system | 1.26987317 |
| 63 | MP0000350_abnormal_cell_proliferation | 1.26829002 |
| 64 | MP0002723_abnormal_immune_serum | 1.25784559 |
| 65 | MP0000313_abnormal_cell_death | 1.21558375 |
| 66 | MP0008872_abnormal_physiological_respon | 1.19930275 |
| 67 | MP0001730_embryonic_growth_arrest | 1.19334887 |
| 68 | MP0002419_abnormal_innate_immunity | 1.18063904 |
| 69 | MP0003646_muscle_fatigue | 1.17255218 |
| 70 | MP0001293_anophthalmia | 1.17001139 |
| 71 | MP0003011_delayed_dark_adaptation | 1.16758180 |
| 72 | MP0004147_increased_porphyrin_level | 1.15729053 |
| 73 | MP0003718_maternal_effect | 1.14506815 |
| 74 | MP0000343_altered_response_to | 1.12826440 |
| 75 | MP0000358_abnormal_cell_content/ | 1.12488752 |
| 76 | MP0001790_abnormal_immune_system | 1.11788393 |
| 77 | MP0005387_immune_system_phenotype | 1.11788393 |
| 78 | MP0000703_abnormal_thymus_morphology | 1.11786671 |
| 79 | MP0003123_paternal_imprinting | 1.08306882 |
| 80 | MP0010352_gastrointestinal_tract_polyps | 1.08030194 |
| 81 | MP0000465_gastrointestinal_hemorrhage | 1.07291081 |
| 82 | MP0004133_heterotaxia | 1.05135429 |
| 83 | MP0005464_abnormal_platelet_physiology | 1.02150493 |
| 84 | MP0001845_abnormal_inflammatory_respons | 1.01666341 |
| 85 | MP0002210_abnormal_sex_determination | 1.01322357 |
| 86 | MP0002234_abnormal_pharynx_morphology | 0.99881812 |
| 87 | MP0000516_abnormal_urinary_system | 0.98082510 |
| 88 | MP0005367_renal/urinary_system_phenotyp | 0.98082510 |
| 89 | MP0001905_abnormal_dopamine_level | 0.97605519 |
| 90 | MP0005075_abnormal_melanosome_morpholog | 0.97064047 |
| 91 | MP0008469_abnormal_protein_level | 0.96243133 |
| 92 | MP0005332_abnormal_amino_acid | 0.96233158 |
| 93 | MP0005379_endocrine/exocrine_gland_phen | 0.96096579 |
| 94 | MP0001929_abnormal_gametogenesis | 0.94690500 |
| 95 | MP0010155_abnormal_intestine_physiology | 0.93630185 |
| 96 | MP0002080_prenatal_lethality | 0.93227629 |
| 97 | MP0005389_reproductive_system_phenotype | 0.92053682 |
| 98 | MP0005645_abnormal_hypothalamus_physiol | 0.91522696 |
| 99 | MP0004782_abnormal_surfactant_physiolog | 0.91305675 |
| 100 | MP0001697_abnormal_embryo_size | 0.89979582 |
| 101 | MP0005636_abnormal_mineral_homeostasis | 0.89865573 |
| 102 | MP0005084_abnormal_gallbladder_morpholo | 0.89756282 |
| 103 | MP0003567_abnormal_fetal_cardiomyocyte | 0.88779279 |
| 104 | MP0000653_abnormal_sex_gland | 0.88162060 |
| 105 | MP0002751_abnormal_autonomic_nervous | 0.87419902 |
| 106 | MP0003221_abnormal_cardiomyocyte_apopto | 0.87324625 |
| 107 | MP0001119_abnormal_female_reproductive | 0.86094844 |
| 108 | MP0001145_abnormal_male_reproductive | 0.85870359 |
| 109 | MP0009840_abnormal_foam_cell | 0.84916103 |
| 110 | MP0001542_abnormal_bone_strength | 0.84915364 |
| 111 | MP0006082_CNS_inflammation | 0.84547883 |
| 112 | MP0005395_other_phenotype | 0.84350850 |
| 113 | MP0003315_abnormal_perineum_morphology | 0.83441776 |
| 114 | MP0008873_increased_physiological_sensi | 0.82947965 |
| 115 | MP0003136_yellow_coat_color | 0.80508153 |
| 116 | MP0001533_abnormal_skeleton_physiology | 0.78926024 |
| 117 | MP0005253_abnormal_eye_physiology | 0.78594644 |
| 118 | MP0005174_abnormal_tail_pigmentation | 0.78438265 |
| 119 | MP0006035_abnormal_mitochondrial_morpho | 0.78170099 |
| 120 | MP0002006_tumorigenesis | 0.77101194 |
| 121 | MP0005394_taste/olfaction_phenotype | 0.76938479 |
| 122 | MP0005499_abnormal_olfactory_system | 0.76938479 |
| 123 | MP0001764_abnormal_homeostasis | 0.75598587 |
| 124 | MP0003279_aneurysm | 0.75294072 |
| 125 | MP0005023_abnormal_wound_healing | 0.75056432 |
| 126 | MP0010368_abnormal_lymphatic_system | 0.74538290 |
| 127 | MP0005410_abnormal_fertilization | 0.73650444 |
| 128 | MP0009697_abnormal_copulation | 0.72934860 |
| 129 | MP0002166_altered_tumor_susceptibility | 0.71613226 |
| 130 | MP0001919_abnormal_reproductive_system | 0.71183604 |
| 131 | MP0001968_abnormal_touch/_nociception | 0.69481241 |
| 132 | MP0000749_muscle_degeneration | 0.69313776 |
| 133 | MP0003941_abnormal_skin_development | 0.69200330 |
| 134 | MP0002138_abnormal_hepatobiliary_system | 0.68173874 |
| 135 | MP0005384_cellular_phenotype | 0.67198167 |
| 136 | MP0000372_irregular_coat_pigmentation | 0.66734122 |
| 137 | MP0000598_abnormal_liver_morphology | 0.66157024 |
| 138 | MP0010307_abnormal_tumor_latency | 0.65493390 |
| 139 | MP0005551_abnormal_eye_electrophysiolog | 0.65383329 |
| 140 | MP0002095_abnormal_skin_pigmentation | 0.64922581 |
| 141 | MP0001346_abnormal_lacrimal_gland | 0.64762600 |
| 142 | MP0010030_abnormal_orbit_morphology | 0.64703805 |
| 143 | MP0001727_abnormal_embryo_implantation | 0.64117572 |
| 144 | MP0002160_abnormal_reproductive_system | 0.63459333 |
| 145 | MP0005621_abnormal_cell_physiology | 0.63060340 |
| 146 | MP0005266_abnormal_metabolism | 0.63013271 |
| 147 | MP0001873_stomach_inflammation | 0.62519120 |
| 148 | MP0005408_hypopigmentation | 0.61572459 |
| 149 | MP0002653_abnormal_ependyma_morphology | 0.61375163 |
| 150 | MP0000613_abnormal_salivary_gland | 0.60807079 |
| 151 | MP0001485_abnormal_pinna_reflex | 0.60418271 |
| 152 | MP0003119_abnormal_digestive_system | 0.57495294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.54635388 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 4.52996338 |
| 3 | Reticulocytopenia (HP:0001896) | 4.33556881 |
| 4 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.14191720 |
| 5 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.14191720 |
| 6 | Aplastic anemia (HP:0001915) | 3.94750271 |
| 7 | Cerebral edema (HP:0002181) | 3.58494590 |
| 8 | Birth length less than 3rd percentile (HP:0003561) | 3.40354898 |
| 9 | Type I transferrin isoform profile (HP:0003642) | 3.25595158 |
| 10 | Methylmalonic acidemia (HP:0002912) | 3.25205059 |
| 11 | Thrombocytosis (HP:0001894) | 3.21568400 |
| 12 | Methylmalonic aciduria (HP:0012120) | 3.19051861 |
| 13 | Oral leukoplakia (HP:0002745) | 3.15154761 |
| 14 | Hepatocellular necrosis (HP:0001404) | 3.12628023 |
| 15 | Microretrognathia (HP:0000308) | 3.09473230 |
| 16 | Hepatic necrosis (HP:0002605) | 3.08250735 |
| 17 | Abnormality of the anterior horn cell (HP:0006802) | 3.06459727 |
| 18 | Degeneration of anterior horn cells (HP:0002398) | 3.06459727 |
| 19 | Reduced antithrombin III activity (HP:0001976) | 3.06441782 |
| 20 | Microvesicular hepatic steatosis (HP:0001414) | 2.94864593 |
| 21 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.91163738 |
| 22 | Pallor (HP:0000980) | 2.83808610 |
| 23 | Mitochondrial inheritance (HP:0001427) | 2.80770958 |
| 24 | Increased serum lactate (HP:0002151) | 2.80546474 |
| 25 | Exertional dyspnea (HP:0002875) | 2.77356780 |
| 26 | Macrocytic anemia (HP:0001972) | 2.73155707 |
| 27 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.71488006 |
| 28 | Rough bone trabeculation (HP:0100670) | 2.69126827 |
| 29 | Increased CSF lactate (HP:0002490) | 2.68380925 |
| 30 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.67163239 |
| 31 | Abnormal protein glycosylation (HP:0012346) | 2.62723629 |
| 32 | Abnormal glycosylation (HP:0012345) | 2.62723629 |
| 33 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.62723629 |
| 34 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.62723629 |
| 35 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.62023850 |
| 36 | Poor head control (HP:0002421) | 2.61399808 |
| 37 | Petechiae (HP:0000967) | 2.60721354 |
| 38 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.59196629 |
| 39 | Abnormality of alanine metabolism (HP:0010916) | 2.59196629 |
| 40 | Hyperalaninemia (HP:0003348) | 2.59196629 |
| 41 | Lethargy (HP:0001254) | 2.57010109 |
| 42 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.54033293 |
| 43 | Increased hepatocellular lipid droplets (HP:0006565) | 2.51438090 |
| 44 | Optic disc pallor (HP:0000543) | 2.51288727 |
| 45 | Acute necrotizing encephalopathy (HP:0006965) | 2.48462244 |
| 46 | Lipid accumulation in hepatocytes (HP:0006561) | 2.46854880 |
| 47 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.44422703 |
| 48 | Multiple enchondromatosis (HP:0005701) | 2.40883337 |
| 49 | Abnormality of methionine metabolism (HP:0010901) | 2.38996904 |
| 50 | Leukodystrophy (HP:0002415) | 2.38940466 |
| 51 | CNS demyelination (HP:0007305) | 2.38261323 |
| 52 | Breast hypoplasia (HP:0003187) | 2.37300277 |
| 53 | 3-Methylglutaconic aciduria (HP:0003535) | 2.37159880 |
| 54 | Lactic acidosis (HP:0003128) | 2.36515049 |
| 55 | Increased serum pyruvate (HP:0003542) | 2.35923947 |
| 56 | Vertebral compression fractures (HP:0002953) | 2.35466518 |
| 57 | Muscle fiber atrophy (HP:0100295) | 2.34164996 |
| 58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.33937233 |
| 59 | Dicarboxylic aciduria (HP:0003215) | 2.33937233 |
| 60 | Type 2 muscle fiber atrophy (HP:0003554) | 2.32184176 |
| 61 | Increased intramyocellular lipid droplets (HP:0012240) | 2.32036091 |
| 62 | IgM deficiency (HP:0002850) | 2.30936299 |
| 63 | Hyperglycinemia (HP:0002154) | 2.28840770 |
| 64 | Trismus (HP:0000211) | 2.28146908 |
| 65 | Abnormality of renal resorption (HP:0011038) | 2.23270553 |
| 66 | Increased muscle lipid content (HP:0009058) | 2.20811507 |
| 67 | Pancytopenia (HP:0001876) | 2.20235870 |
| 68 | Abnormality of urine glucose concentration (HP:0011016) | 2.18567033 |
| 69 | Glycosuria (HP:0003076) | 2.18567033 |
| 70 | Carpal bone hypoplasia (HP:0001498) | 2.17895984 |
| 71 | Pancreatic cysts (HP:0001737) | 2.17893934 |
| 72 | Respiratory difficulties (HP:0002880) | 2.17147738 |
| 73 | Abnormality of glycolysis (HP:0004366) | 2.17097838 |
| 74 | Exercise intolerance (HP:0003546) | 2.16229399 |
| 75 | 11 pairs of ribs (HP:0000878) | 2.15949873 |
| 76 | Myositis (HP:0100614) | 2.15841633 |
| 77 | Abnormality of serum amino acid levels (HP:0003112) | 2.13825230 |
| 78 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.13408936 |
| 79 | Absent thumb (HP:0009777) | 2.11811993 |
| 80 | Nausea (HP:0002018) | 2.09291358 |
| 81 | Acute encephalopathy (HP:0006846) | 2.07276568 |
| 82 | Premature graying of hair (HP:0002216) | 2.07237079 |
| 83 | Selective tooth agenesis (HP:0001592) | 2.04576719 |
| 84 | Recurrent abscess formation (HP:0002722) | 2.02125347 |
| 85 | Patellar aplasia (HP:0006443) | 2.01917563 |
| 86 | Colon cancer (HP:0003003) | 2.00571733 |
| 87 | Progressive muscle weakness (HP:0003323) | 1.97285875 |
| 88 | Bone marrow hypocellularity (HP:0005528) | 1.95953168 |
| 89 | Abnormality of the pons (HP:0007361) | 1.95573142 |
| 90 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.95452644 |
| 91 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.94907312 |
| 92 | Emotional lability (HP:0000712) | 1.92133323 |
| 93 | Hypoglycemic coma (HP:0001325) | 1.90446873 |
| 94 | Testicular atrophy (HP:0000029) | 1.90432600 |
| 95 | Abnormal trabecular bone morphology (HP:0100671) | 1.90384444 |
| 96 | Abnormality of placental membranes (HP:0011409) | 1.89807970 |
| 97 | Amniotic constriction ring (HP:0009775) | 1.89807970 |
| 98 | Pulmonary fibrosis (HP:0002206) | 1.88735621 |
| 99 | Cellular immunodeficiency (HP:0005374) | 1.88518814 |
| 100 | Hypoplasia of the pons (HP:0012110) | 1.88093335 |
| 101 | Myelodysplasia (HP:0002863) | 1.87717168 |
| 102 | Generalized aminoaciduria (HP:0002909) | 1.86440783 |
| 103 | Cerebral hypomyelination (HP:0006808) | 1.86422782 |
| 104 | Cleft eyelid (HP:0000625) | 1.86299870 |
| 105 | Renal Fanconi syndrome (HP:0001994) | 1.85912425 |
| 106 | Respiratory failure (HP:0002878) | 1.85798319 |
| 107 | Pancreatic fibrosis (HP:0100732) | 1.82831120 |
| 108 | Sparse eyelashes (HP:0000653) | 1.82230025 |
| 109 | Abnormality of T cell physiology (HP:0011840) | 1.82178147 |
| 110 | Neutropenia (HP:0001875) | 1.81724618 |
| 111 | Secondary amenorrhea (HP:0000869) | 1.80452004 |
| 112 | X-linked dominant inheritance (HP:0001423) | 1.79935056 |
| 113 | Hypothermia (HP:0002045) | 1.79739473 |
| 114 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.78666277 |
| 115 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.78532713 |
| 116 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.78114208 |
| 117 | Abnormality of chromosome stability (HP:0003220) | 1.76563053 |
| 118 | Poikiloderma (HP:0001029) | 1.76531355 |
| 119 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.76468901 |
| 120 | True hermaphroditism (HP:0010459) | 1.76238418 |
| 121 | Neoplasm of the adrenal gland (HP:0100631) | 1.75902648 |
| 122 | Beaking of vertebral bodies (HP:0004568) | 1.75432228 |
| 123 | Dry hair (HP:0011359) | 1.74281458 |
| 124 | Abnormality of reticulocytes (HP:0004312) | 1.72598382 |
| 125 | Sclerocornea (HP:0000647) | 1.72104938 |
| 126 | Abnormality of the labia minora (HP:0012880) | 1.71757015 |
| 127 | Abnormality of homocysteine metabolism (HP:0010919) | 1.71632010 |
| 128 | Homocystinuria (HP:0002156) | 1.71632010 |
| 129 | Abnormality of vitamin B metabolism (HP:0004340) | 1.70894557 |
| 130 | Progressive macrocephaly (HP:0004481) | 1.70274682 |
| 131 | Lymphoma (HP:0002665) | 1.70153903 |
| 132 | Ketoacidosis (HP:0001993) | 1.69928040 |
| 133 | Slender long bone (HP:0003100) | 1.69926077 |
| 134 | Abnormal biliary tract physiology (HP:0012439) | 1.68049151 |
| 135 | Bile duct proliferation (HP:0001408) | 1.68049151 |
| 136 | Neoplasm of the pancreas (HP:0002894) | 1.65704747 |
| 137 | Recurrent bacterial skin infections (HP:0005406) | 1.65268375 |
| 138 | Optic nerve coloboma (HP:0000588) | 1.62627937 |
| 139 | Meckel diverticulum (HP:0002245) | 1.62357029 |
| 140 | Rhabdomyolysis (HP:0003201) | 1.60771532 |
| 141 | Abnormality of the preputium (HP:0100587) | 1.60558471 |
| 142 | Chronic otitis media (HP:0000389) | 1.59151367 |
| 143 | Abnormality of the ileum (HP:0001549) | 1.59078639 |
| 144 | Biconcave vertebral bodies (HP:0004586) | 1.59018306 |
| 145 | Premature ovarian failure (HP:0008209) | 1.58351164 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 5.06151587 |
| 2 | BUB1 | 3.71318899 |
| 3 | NME2 | 3.59891812 |
| 4 | WEE1 | 3.00229537 |
| 5 | EIF2AK1 | 2.88519962 |
| 6 | STK16 | 2.84912702 |
| 7 | TRIM28 | 2.69904269 |
| 8 | PIM2 | 2.61253614 |
| 9 | KDR | 2.20983224 |
| 10 | NUAK1 | 2.11889829 |
| 11 | ACVR1B | 2.09252224 |
| 12 | BCKDK | 1.99300076 |
| 13 | TESK2 | 1.96623289 |
| 14 | EIF2AK3 | 1.94791629 |
| 15 | BRSK2 | 1.92353756 |
| 16 | MAP4K2 | 1.91470629 |
| 17 | RPS6KA4 | 1.84754233 |
| 18 | VRK1 | 1.83863078 |
| 19 | DYRK3 | 1.81719069 |
| 20 | PLK3 | 1.78230894 |
| 21 | TESK1 | 1.72305285 |
| 22 | MAPKAPK3 | 1.67010681 |
| 23 | MAP4K1 | 1.65837294 |
| 24 | PLK4 | 1.57240278 |
| 25 | MAP3K11 | 1.53565489 |
| 26 | PDK2 | 1.53018934 |
| 27 | BRAF | 1.45807052 |
| 28 | FLT3 | 1.44929014 |
| 29 | TBK1 | 1.44706940 |
| 30 | ARAF | 1.44587089 |
| 31 | NEK2 | 1.38006712 |
| 32 | TGFBR1 | 1.33405159 |
| 33 | IRAK4 | 1.29768113 |
| 34 | TAF1 | 1.29351216 |
| 35 | MAP2K3 | 1.27764551 |
| 36 | TLK1 | 1.24702776 |
| 37 | CSNK1G3 | 1.22343620 |
| 38 | RPS6KB2 | 1.21965155 |
| 39 | ZAK | 1.20513194 |
| 40 | MAP3K12 | 1.19874820 |
| 41 | NEK1 | 1.19619416 |
| 42 | LRRK2 | 1.17839132 |
| 43 | KIT | 1.17735610 |
| 44 | CDK8 | 1.17513397 |
| 45 | TYK2 | 1.17271198 |
| 46 | MYLK | 1.17175224 |
| 47 | CDK7 | 1.16305661 |
| 48 | GRK1 | 1.15847380 |
| 49 | AURKB | 1.14814554 |
| 50 | PLK1 | 1.13367958 |
| 51 | IRAK3 | 1.12937670 |
| 52 | BRSK1 | 1.11551198 |
| 53 | WNK3 | 1.09477424 |
| 54 | PASK | 1.07881831 |
| 55 | JAK3 | 1.06777138 |
| 56 | DAPK1 | 1.06410547 |
| 57 | SCYL2 | 1.06248079 |
| 58 | CDC7 | 1.04859158 |
| 59 | MAP3K8 | 1.04087798 |
| 60 | CSNK1G1 | 1.03887657 |
| 61 | TEC | 1.02837059 |
| 62 | ZAP70 | 1.02735562 |
| 63 | FRK | 1.01000429 |
| 64 | AURKA | 1.00616270 |
| 65 | NME1 | 1.00045153 |
| 66 | MKNK1 | 0.99897424 |
| 67 | BLK | 0.99750332 |
| 68 | RAF1 | 0.99531578 |
| 69 | PIM1 | 0.98551153 |
| 70 | STK10 | 0.98418587 |
| 71 | SRPK1 | 0.97842831 |
| 72 | PBK | 0.97638016 |
| 73 | ILK | 0.95550362 |
| 74 | BTK | 0.94079604 |
| 75 | BCR | 0.92482483 |
| 76 | MKNK2 | 0.92475593 |
| 77 | IKBKE | 0.91721497 |
| 78 | LIMK1 | 0.90844051 |
| 79 | IKBKB | 0.89542182 |
| 80 | PIK3CG | 0.88673342 |
| 81 | ERN1 | 0.88596337 |
| 82 | PAK4 | 0.87296102 |
| 83 | CSNK1A1L | 0.86757278 |
| 84 | CSNK1G2 | 0.86480690 |
| 85 | ADRBK2 | 0.86096519 |
| 86 | MAP3K3 | 0.84137852 |
| 87 | ATR | 0.83841444 |
| 88 | NEK9 | 0.77352099 |
| 89 | STK38L | 0.77195651 |
| 90 | ABL2 | 0.76001727 |
| 91 | EIF2AK2 | 0.75048490 |
| 92 | TTK | 0.74780582 |
| 93 | CCNB1 | 0.72471777 |
| 94 | INSRR | 0.71687408 |
| 95 | SIK3 | 0.70835732 |
| 96 | NLK | 0.69958114 |
| 97 | EEF2K | 0.69505849 |
| 98 | TXK | 0.68225172 |
| 99 | CHEK2 | 0.66768313 |
| 100 | TAOK2 | 0.64765385 |
| 101 | PAK1 | 0.64318855 |
| 102 | CDK19 | 0.62052084 |
| 103 | CSNK2A2 | 0.61054626 |
| 104 | STK4 | 0.59914807 |
| 105 | MST4 | 0.59057306 |
| 106 | DAPK3 | 0.58560274 |
| 107 | DYRK2 | 0.55532280 |
| 108 | OXSR1 | 0.55460207 |
| 109 | MOS | 0.53760316 |
| 110 | RPS6KA5 | 0.53024344 |
| 111 | CSNK2A1 | 0.52954715 |
| 112 | CDK4 | 0.52075763 |
| 113 | MAPK11 | 0.51960191 |
| 114 | BMPR1B | 0.51545516 |
| 115 | TIE1 | 0.48103814 |
| 116 | CHUK | 0.47923609 |
| 117 | MUSK | 0.47441322 |
| 118 | TSSK6 | 0.46286631 |
| 119 | SYK | 0.46154065 |
| 120 | CLK1 | 0.46066330 |
| 121 | MAPKAPK2 | 0.44712446 |
| 122 | TNIK | 0.44284152 |
| 123 | PRKCI | 0.41608118 |
| 124 | LYN | 0.40725785 |
| 125 | MARK3 | 0.40248582 |
| 126 | CHEK1 | 0.39894710 |
| 127 | MAP3K10 | 0.38105499 |
| 128 | MAP2K7 | 0.35643840 |
| 129 | PLK2 | 0.34941373 |
| 130 | ATM | 0.34326858 |
| 131 | MAP2K6 | 0.32153725 |
| 132 | CSNK1A1 | 0.30655792 |
| 133 | CDK3 | 0.28373125 |
| 134 | MAPKAPK5 | 0.26573706 |
| 135 | PRKCG | 0.24036252 |
| 136 | ADRBK1 | 0.18150175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.33410976 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.16854841 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.97663957 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.28999837 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 3.05966157 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.79080671 |
| 7 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.64345983 |
| 8 | Protein export_Homo sapiens_hsa03060 | 2.53193927 |
| 9 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.48780214 |
| 10 | Spliceosome_Homo sapiens_hsa03040 | 2.34515566 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 2.27571255 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.26498001 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.05944722 |
| 14 | * RNA transport_Homo sapiens_hsa03013 | 1.91824966 |
| 15 | Cell cycle_Homo sapiens_hsa04110 | 1.87379154 |
| 16 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.65138063 |
| 17 | Parkinsons disease_Homo sapiens_hsa05012 | 1.60145793 |
| 18 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.55415925 |
| 19 | RNA degradation_Homo sapiens_hsa03018 | 1.50090976 |
| 20 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.49660599 |
| 21 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.47543747 |
| 22 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.47075185 |
| 23 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.42133302 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.40727216 |
| 25 | Basal transcription factors_Homo sapiens_hsa03022 | 1.39577398 |
| 26 | Sulfur relay system_Homo sapiens_hsa04122 | 1.38274552 |
| 27 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.35599347 |
| 28 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.34530443 |
| 29 | Purine metabolism_Homo sapiens_hsa00230 | 1.34277472 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.29873109 |
| 31 | Huntingtons disease_Homo sapiens_hsa05016 | 1.29666407 |
| 32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.22275576 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.20358868 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.17431426 |
| 35 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.14387987 |
| 36 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.13256992 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11948312 |
| 38 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.11564832 |
| 39 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.10825924 |
| 40 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.10658355 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.08386385 |
| 42 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.03019355 |
| 43 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.02776043 |
| 44 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.99295522 |
| 45 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98876779 |
| 46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.97639182 |
| 47 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95158577 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.89894565 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 0.86711548 |
| 50 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.86337811 |
| 51 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.85323673 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.84348577 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83983201 |
| 54 | Leishmaniasis_Homo sapiens_hsa05140 | 0.83556391 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.80619065 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 0.80206050 |
| 57 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.77963771 |
| 58 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77723007 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 0.76110123 |
| 60 | Galactose metabolism_Homo sapiens_hsa00052 | 0.75254381 |
| 61 | Measles_Homo sapiens_hsa05162 | 0.74997801 |
| 62 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.74138949 |
| 63 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.71570405 |
| 64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.70965694 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.69601603 |
| 66 | Apoptosis_Homo sapiens_hsa04210 | 0.69161133 |
| 67 | Alzheimers disease_Homo sapiens_hsa05010 | 0.68319673 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66855715 |
| 69 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.66250512 |
| 70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.66214488 |
| 71 | Allograft rejection_Homo sapiens_hsa05330 | 0.65760955 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.65657776 |
| 73 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.65418856 |
| 74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63713837 |
| 75 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.62510883 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61727886 |
| 77 | Thyroid cancer_Homo sapiens_hsa05216 | 0.61165398 |
| 78 | Carbon metabolism_Homo sapiens_hsa01200 | 0.59931901 |
| 79 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.57534896 |
| 80 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56528347 |
| 81 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.56075257 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53847811 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53754676 |
| 84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.53168257 |
| 85 | Influenza A_Homo sapiens_hsa05164 | 0.53114931 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52666566 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51537306 |
| 88 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.49858353 |
| 89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46253039 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44988753 |
| 91 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.44935094 |
| 92 | Hepatitis B_Homo sapiens_hsa05161 | 0.44069541 |
| 93 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.43969781 |
| 94 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.43500922 |
| 95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43015880 |
| 96 | Asthma_Homo sapiens_hsa05310 | 0.42817953 |
| 97 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.42378403 |
| 98 | Malaria_Homo sapiens_hsa05144 | 0.41542459 |
| 99 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.41126653 |
| 100 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.38603746 |
| 101 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.38430570 |
| 102 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.38385282 |
| 103 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.38313868 |
| 104 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.38288123 |
| 105 | Pertussis_Homo sapiens_hsa05133 | 0.38203654 |
| 106 | Phototransduction_Homo sapiens_hsa04744 | 0.37591776 |
| 107 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.37545328 |
| 108 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.37177117 |
| 109 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.34473126 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34104918 |
| 111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.33313988 |
| 112 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.33058877 |
| 113 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.32244517 |
| 114 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.31041484 |
| 115 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.30089626 |
| 116 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.29517456 |
| 117 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.29079567 |
| 118 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.28945508 |
| 119 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28677714 |
| 120 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.26806311 |
| 121 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.26659340 |
| 122 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.26416324 |
| 123 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.25773358 |
| 124 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.24623547 |
| 125 | Bladder cancer_Homo sapiens_hsa05219 | 0.24573025 |
| 126 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.23660310 |
| 127 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23553697 |
| 128 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.22519395 |
| 129 | Tuberculosis_Homo sapiens_hsa05152 | 0.22176399 |
| 130 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.21994272 |
| 131 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.21569665 |
| 132 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.20958134 |
| 133 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.20020741 |
| 134 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.19620270 |
| 135 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.19350371 |
| 136 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.18633135 |

